SFr. 87.00
€ 93.96
BTC 0.0015
LTC 1.279
ETH 0.0276


bestellen

Artikel-Nr. 29867031


Diesen Artikel in meine
Wunschliste
Diesen Artikel
weiterempfehlen
Diesen Preis
beobachten

Weitersagen:


Herausgeber: 
  • Clare Stroud
  • Lisa Bain
    Autor(en): 
  • Board on Health Sciences Policy
  • Health and Medicine Division
  • Forum on Neuroscience and Nervous System Disorders
  • National Academies of Sciences Engineering and Med
  • Advancing Gene-Targeted Therapies for Central Nervous System Disorders: Proceedings of a Workshop 
     

    (Buch)
    Dieser Artikel gilt, aufgrund seiner Grösse, beim Versand als 3 Artikel!


    Übersicht

    Auf mobile öffnen
     
    Lieferstatus:   Auf Bestellung (Lieferzeit unbekannt)
    Veröffentlichung:  Dezember 2019  
    Genre:  Naturwissensch., Medizin, Technik 
     
    Gesundheitssystem und Gesundheitswesen / MEDICAL / Allied Health Services / Medical Technology / MEDICAL / Health Policy / Medical / Nursing / MEDICAL / Research
    ISBN:  9780309495844 
    EAN-Code: 
    9780309495844 
    Verlag:  National Academies Press 
    Einband:  Kartoniert  
    Sprache:  English  
    Seiten:  92 
    Bewertung: Titel bewerten / Meinung schreiben
    Inhalt:
    "On April 23 and 24, 2019 the Forum on Neuroscience and Nervous System Disorders convened a workshop titled "Advancing Gene-Targeted Therapies for Central Nervous System Disorders" in Washington, DC. This public workshop brought together experts and key stakeholders from academia, government, industry, philanthropic foundations, and disease/patient-focused nonprofit organizations to explore approaches for advancing the development of gene-targeted therapies for central nervous system (CNS) disorders, and implications of developing these therapies. Participants explored lessons learned from both successful and unsuccessful clinical development programs; new knowledge about the genetic underpinnings of brain disorders; the current status and future potential of gene-targeted therapies for CNS disorders; challenges and potential solutions for translating preclinical findings to approved therapies; and patient and caregiver perspectives. They also discussed what will be needed to develop these therapies for common disorders such as Alzheimer's and Parkinson's disease, as well as neuropsychiatric and neurodevelopmental disorders such as schizophrenia and autism. The workshop included approaches that target both DNA and RNA, as well as gene products using viral vectors, antisense oligonucleotides, and RNA interference. This publication summarizes the presentations and discussion of the workshop"--Publisher's description

      



    Wird aktuell angeschaut...
     

    Zurück zur letzten Ansicht


    AGB | Datenschutzerklärung | Mein Konto | Impressum | Partnerprogramm
    Newsletter | 1Advd.ch RSS News-Feed Newsfeed | 1Advd.ch Facebook-Page Facebook | 1Advd.ch Twitter-Page Twitter
    Forbidden Planet AG © 1999-2024
    Alle Angaben ohne Gewähr
     
    SUCHEN

     
     Kategorien
    Im Sortiment stöbern
    Genres
    Hörbücher
    Aktionen
     Infos
    Mein Konto
    Warenkorb
    Meine Wunschliste
     Kundenservice
    Recherchedienst
    Fragen / AGB / Kontakt
    Partnerprogramm
    Impressum
    © by Forbidden Planet AG 1999-2024